Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Oral heparin completes phase I testing

May 10, 2001

Promising preclinical data reported for argatroban in rat ischemic stroke model

May 10, 2001

Inhibitors of factor Xa under development at Cor Therapeutics

May 8, 2001

Novel P2T receptor antagonists identified at AstraZeneca as potential antithrombotics

May 8, 2001

Antithrombotic activity of agkistin related to platelet gpIb antagonism

May 8, 2001

Reviparin compared to heparin in deep vein thrombosis

May 4, 2001

Protein enters preclinical development for acute thrombosis at Myriad Genetics

May 3, 2001

Antithrombotic pentasaccharide assigned fast track review by FDA

May 3, 2001

3-D's new serine protease inhibitors and their use disclosed in recent patent

May 2, 2001

Potent anticoagulant activity of ART-123 associated with reduced effects on hemostasis

April 24, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...